Home » How to Manage Tariffs in Pharmaceutical Packaging
How to Manage Tariffs in Pharmaceutical Packaging

For pharmaceutical companies, sourcing packaging has become more complex in recent years. Tariffs on imported materials and printed components are creating pricing pressure, disrupting long-term contracts, and forcing many buyers to rethink where and how they source their packaging.
Whether you rely on overseas suppliers or work with a domestic partner who sources internationally, tariffs can affect the cost and availability of critical packaging components like folding cartons, blister packs, inserts, and corrugated shippers.
Here’s how to understand the impact—and what you can do to stay ahead.
Know What’s Being Taxed
Not all pharmaceutical packaging is affected by tariffs in the same way. Many of the items commonly used in pharma packaging fall under categories that have been hit with tariffs in recent U.S.–China trade actions.
These may include:
- Printed folding cartons and inserts
- Blister pack materials (including PVC and foil)
- Corrugated shipper boxes
- Labels and leaflets
- Some specialty coatings and substrates
Tariff rates can vary, depending on the material, country of origin, and current trade policy. What seems like a small increase per unit can lead to massive cost increases at scale.

Review Your Supplier’s Origin and Production Model
Even if your supplier is based in the U.S., they may still source raw materials, substrates, or finished packaging components from tariff-impacted countries.
It’s important to ask:
- Where is each component of my packaging produced?
- Does the supplier import printed materials or raw board?
- Are any secondary processes (like lamination or foil stamping) outsourced overseas?
Understanding your true supply chain origin helps you identify where the tariff risks are—so you can plan ahead.
Reevaluate Total Cost of Ownership
Increased tariffs often eliminate the price advantage that used to come with overseas packaging. When you factor in:
- Tariffs
- Rising freight costs
- Port delays and longer lead times
- Quality control or communication issues
You may find that domestic packaging suppliers are now more competitive on both cost and reliability.

Talk to Your Packaging Supplier About Domestic Alternatives
If you’re concerned about exposure to tariffs, a proactive supplier should be able to:
- Offer U.S.-made or NAFTA-friendly alternatives
- Suggest design or material changes to reduce cost impact
- Help consolidate SKUs or adjust specs to simplify sourcing
- Provide packaging that meets FDA labeling and compliance requirements domestically
Shifting to U.S.-based production doesn’t always mean higher cost—it often brings improved supply chain visibility, faster lead times, and fewer surprises.
Factor Tariffs Into Long-Term Strategy
If you’re renegotiating contracts, launching new SKUs, or scaling production, factor tariff risk into your 12–24 month outlook. Ask your supplier:
- Can they lock in pricing or hold stock domestically?
- Do they have backup sourcing options if trade rules change again?
- Are they monitoring tariff changes and proactively communicating impacts?
Being reactive to tariffs leads to missed margins and production delays. Building flexibility into your packaging strategy now can protect your product pipeline later.

Final Thoughts
Tariffs are no longer a temporary nuisance—they’re a permanent part of global sourcing. For pharmaceutical brands, that means understanding where your packaging is coming from, how trade policy affects it, and what options exist to reduce risk and cost.
Looking for help minimizing tariff exposure on your pharmaceutical packaging?
We can walk you through domestic solutions, supply chain planning, and structural design adjustments to keep your product protected and your packaging program compliant.
As the 2025 holiday season approaches, retailers are gearing up for what promises to be another bustling period of consumer activity. For brands looking to capitalize on this seasonal surge,
For pharmaceutical companies, sourcing packaging has become more complex in recent years. Tariffs on imported materials and printed components are creating pricing pressure, disrupting long-term contracts, and forcing many buyers
Your packaging budget isn’t just about cost—it’s about timing, opportunity, and alignment with your business goals. Sticking with the same spend year after year might feel safe, but it could
Why Packaging Automation Compatibility Matters As more fulfillment centers, contract packagers, and manufacturers turn to automation, packaging that isn’t compatible with machinery becomes a costly bottleneck. From misfeeds on case
Home » How to Manage Tariffs in Pharmaceutical Packaging